{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:09:43Z","timestamp":1793232583381,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People who inject drugs (PWID) are at risk of HIV acquisition. The number of PWID in South African cities is increasing, and in spite of an advanced HIV prevention and treatment programme, there are PWID who experience challenges accessing sexual and reproductive health (SRH) and HIV related services. Access to and acceptability of SRH and harm reduction services by PWID needs to be further understood and explored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In-depth interviews (IDIs) were conducted with 10 key stakeholders and 11 PWID, in Durban, South Africa. Interviews were transcribed and translated. Data were thematically analysed using Dedoose software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants described stigma\/discrimination from healthcare workers and other clients accessing services as barriers to accessing healthcare services. They were concerned about long waiting times at healthcare facilities because of possibilities of withdrawal, as well as lost opportunities to \u201chustle\u201d. Targeted, non-discriminatory services, as well as mobile clinics existed in the city. Non-governmental organisations reportedly worked together with the public sector, facilitating access to HIV and TB prevention and treatment services. There were also needle exchange programmes and a harm reduction clinic in the city. However, there was limited access to contraceptive and STI services. Although there was reportedly good access to HIV and TB and harm reduction services in the city of Durban, uptake was low.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The integration of services to enable PWID to access different services under one roof is critical. There is also a need to strengthen linkages between public and private healthcare, and ensure services are provided in a non-discriminatory environment. This will facilitate uptake and access to more comprehensive SRH and harm reduction services for PWID in Durban, South Africa.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-024-01042-6","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:29:07Z","timestamp":1719401347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Access to and acceptability of sexual and reproductive health, harm reduction and other essential health services among people who inject drugs in Durban, South Africa"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0026-7560","authenticated-orcid":false,"given":"Cecilia","family":"Milford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammany","family":"Cavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Bosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Zanoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"1042_CR1","volume-title":"Self-reported stigma and equity of healthcare service delivery for people living with HIV who use drugs in South Africa","author":"V Macotha","year":"2022","unstructured":"Macotha V, Mabaso M, Cloete A, Naqvi N, Murangandi P, Sobane K, et al. Self-reported stigma and equity of healthcare service delivery for people living with HIV who use drugs in South Africa. November: HSRC Policy Brief; 2022."},{"key":"1042_CR2","unstructured":"Country factsheets: South Africa. 2022. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/southafrica. Accessed 17 Oct 2023."},{"key":"1042_CR3","doi-asserted-by":"publisher","first-page":"e25707","DOI":"10.1002\/jia2.25707","volume":"24","author":"LC Long","year":"2021","unstructured":"Long LC, Rosen S, Nichols B, Larson BA, Ndlovu N, Meyer-Rath G. Getting resources to those who need them: the evidence we need to budget for underserved populations in sub\u2010Saharan Africa. J Int AIDS Soc. 2021;24:e25707.","journal-title":"J Int AIDS Soc"},{"key":"1042_CR4","volume-title":"Hiding in plain sight. Heroin\u2019s stealthy takeover of South Africa. Policy brief","author":"S Haysom","year":"2019","unstructured":"Haysom S. Hiding in plain sight. Heroin\u2019s stealthy takeover of South Africa. Policy brief. Pretoria: ENACT; 2019."},{"issue":"1","key":"1042_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-019-0298-2","volume":"16","author":"A Scheibe","year":"2019","unstructured":"Scheibe A, Young K, Moses L, Basson RL, Versfeld A, Spearman CW, et al. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Harm Reduct J. 2019;16(1):1\u201311.","journal-title":"Harm Reduct J"},{"key":"1042_CR6","unstructured":"Key Population Atlas. https:\/\/kpatlas.unaids.org\/dashboard?_ga=2.148279423.953851738.1688027945-1084586244.1655199679&_gl=1%2a4m6e23%2a_ga%2aMTA4NDU4NjI0NC4xNjU1MTk5Njc5%2a_ga_T7FBEZEXNC%2aMTY4ODAyNzk0NC4xLjEuMTY4ODAyODg4OS42MC4wLjA. Accessed 16 Oct 2023."},{"key":"1042_CR7","unstructured":"Setswe G, Wabiri N, Cloete A, Mabaso M, Jooste S, Ntsepe Y et al. Programmatic mapping and size estimation of key populations: sex workers, men who have sex with men, people who inject drugs and transgender people. 21st International AIDS Conference; 18\u201322 July 2016; Durban, South Africa2016."},{"key":"1042_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-10-13","volume":"10","author":"Z Petersen","year":"2013","unstructured":"Petersen Z, Myers B, Van Hout MC, Pl\u00fcddemann A, Parry C. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries. Harm Reduct J. 2013;10:1\u20137.","journal-title":"Harm Reduct J"},{"issue":"5","key":"1042_CR9","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/S2352-3018(19)30112-2","volume":"6","author":"Editorial","year":"2019","unstructured":"Editorial. The war on drugs is incompatible with the fight against HIV \u2013 editorial. Lancet HIV. 2019;6(5):e269.","journal-title":"Lancet HIV"},{"key":"1042_CR10","volume-title":"Health, rights and drugs\u2014harm reduction, decriminalization and zero discrimination for people who use drugs","author":"Joint United Nations Programme on HIV\/AIDS","year":"2019","unstructured":"Joint United Nations Programme on HIV\/AIDS. Health, rights and drugs\u2014harm reduction, decriminalization and zero discrimination for people who use drugs. Geneva, Switzerland: UNAIDS; 2019."},{"key":"1042_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05359-y","volume":"20","author":"A Scheibe","year":"2020","unstructured":"Scheibe A, Young K, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, et al. Hepatitis B, Hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017). BMC Infect Dis. 2020;20:1\u201315.","journal-title":"BMC Infect Dis"},{"key":"1042_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.forsciint.2019.04.040","volume":"300","author":"PM Mthembi","year":"2019","unstructured":"Mthembi PM, Mwenesongole EM, Cole MD. Chemical profiling of the street cocktail drug \u2018nyaope\u2019 in South Africa using GC\u2013MS II: Stability studies of the cannabinoid, opiate and antiretroviral components during sample storage. Forensic Sci Int. 2019;300:187\u201392.","journal-title":"Forensic Sci Int"},{"issue":"1","key":"1042_CR13","first-page":"2416","volume":"13","author":"MH Lefoka","year":"2021","unstructured":"Lefoka MH, Netangaheni TR. A plea of those who are affected most by HIV: the utterances by women who inject nyaope residing in the City of Tshwane Municipality. Gauteng Afr J Prim Health care Family Med. 2021;13(1):2416.","journal-title":"Gauteng Afr J Prim Health care Family Med"},{"issue":"1","key":"1042_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.14745\/ccdr.v39i01a02","volume":"39","author":"D Paquette","year":"2013","unstructured":"Paquette D, Demers A, Gale-Rowe M, Wong T. Brief\u2014synopsis of the current evidence on the risk of HIV transmission. Can Commun Dis Rep. 2013;39(1):9.","journal-title":"Can Commun Dis Rep"},{"key":"1042_CR15","unstructured":"Waweru N. Report reveals shocking bluetoothing habit among drug addicts in South Africa. 2018. https:\/\/face2faceafrica.com\/article\/report-reveals-shocking-bluetoothing-habit-among-drug-addicts-in-south-africa-video. Accessed 28 Oct 2023."},{"key":"1042_CR16","unstructured":"Sparks J. \u2018Bluetoothing\u2019: Why addicts in South Africa are injecting each other\u2019s blood. 2018. https:\/\/news.sky.com\/story\/bluetoothing-why-addicts-in-south-africa-are-injecting-each-others-blood-11388290. Accessed 28 Oct 2023."},{"issue":"5","key":"1042_CR17","doi-asserted-by":"publisher","first-page":"e0281030","DOI":"10.1371\/journal.pone.0281030","volume":"18","author":"B Zanoni","year":"2023","unstructured":"Zanoni B, Milford C, Sithole K, Mosery N, Wilson M, Bosman S, Smit J. High risk injection drug use and uptake of HIV prevention and treatment services among people who inject drugs in KwaZulu-Natal, South Africa. PLoS ONE. 2023;18(5):e0281030.","journal-title":"PLoS ONE"},{"issue":"9737","key":"1042_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","volume":"376","author":"SA Strathdee","year":"2010","unstructured":"Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, Hankins CA. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268\u201384.","journal-title":"Lancet"},{"key":"1042_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2016.01.004","volume":"30","author":"A Scheibe","year":"2016","unstructured":"Scheibe A, Makapela D, Brown B, dos Santos M, Hariga F, Virk H, et al. HIV prevalence and risk among people who inject drugs in five South African cities. Int J Drug Policy. 2016;30:107\u201315.","journal-title":"Int J Drug Policy"},{"key":"1042_CR20","unstructured":"Scheibe A, Matima R, Schneider A, Basson R, Ngcebetsha S, Padayachee K et al. Still left behind: using programmatic data to assess harm reduction service coverage and HIV treatment cascades for people who inject drugs in five South African cities. IAS 2019; 21\u20134 July 2019; Mexico."},{"issue":"12","key":"1042_CR21","doi-asserted-by":"publisher","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","volume":"5","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and Hepatitis C among people who inject drugs: a systematic review. Lancet Global Health. 2017;5(12):e1208\u201320.","journal-title":"Lancet Global Health"},{"issue":"1","key":"1042_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1017\/S0022278X20000658","volume":"59","author":"M Hunter","year":"2021","unstructured":"Hunter M. Intimate crimes: Heroin and the rise of amaphara in South Africa. J Mod Afr Stud. 2021;59(1):59\u201379.","journal-title":"J Mod Afr Stud"},{"issue":"6","key":"1042_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32 item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"1042_CR24","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L et al. REDCap consortium: building an international community of software partners. J Biomed Inform. 2019; May 9.","DOI":"10.1016\/j.jbi.2019.103208"},{"issue":"3","key":"1042_CR25","first-page":"226","volume":"68","author":"J Sutton","year":"2015","unstructured":"Sutton J, Austin Z. Qualitative research: data collection, analysis, and management. Can J Hosp Pharm. 2015;68(3):226\u201331.","journal-title":"Can J Hosp Pharm"},{"issue":"2","key":"1042_CR26","first-page":"77","volume":"14","author":"D Wentzel","year":"2012","unstructured":"Wentzel D, Voce A. Health seeking experiences and behaviours of homeless people in Durban, South Africa. Afr J Nurs Midwifery. 2012;14(2):77\u201389.","journal-title":"Afr J Nurs Midwifery"},{"key":"1042_CR27","doi-asserted-by":"publisher","first-page":"1265063","DOI":"10.3389\/fpubh.2023.1265063","volume":"11","author":"T Dzinamarira","year":"2023","unstructured":"Dzinamarira T, Moyo E. The use of oral HIV pre-exposure prophylaxis among people who inject drugs: barriers, and recommendations. Front Public Health. 2023;11:1265063.","journal-title":"Front Public Health"},{"key":"1042_CR28","doi-asserted-by":"publisher","first-page":"113809","DOI":"10.1016\/j.socscimed.2021.113809","volume":"275","author":"M Felsher","year":"2021","unstructured":"Felsher M, Ziegler E, Amico KR, Carrico A, Coleman J, Roth AM. PrEP just isn\u2019t my priority: adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA. Soc Sci Med. 2021;275:113809.","journal-title":"Soc Sci Med"},{"key":"1042_CR29","unstructured":"van Dyk J. Durban cuts city\u2019s only needle exchange programme. 2018. https:\/\/bhekisisa.org\/health-news-south-africa\/2018-05-30-00-durban-cuts-citys-only-needle-exchange-programme\/. Accessed 17 Oct 2023."},{"issue":"2","key":"1042_CR30","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1097\/QAI.0000000000002169","volume":"82","author":"KH Mayer","year":"2019","unstructured":"Mayer KH, Allan-Bitz LT. PrEP 1.0 and beyond: optimizing a biobehavioral intervention. J Acquir Immunce Defic Syndr. 2019;82(2):S113.","journal-title":"J Acquir Immunce Defic Syndr"},{"key":"1042_CR31","unstructured":"Lopez Gonzalez L. South Africa to begin piloting injectable PrEP in early 2023. 2022. https:\/\/www.aidsmap.com\/news\/nov-2022\/south-africa-begin-piloting-injectable-prep-early-2023. Accessed 17 Oct 2023."},{"issue":"1","key":"1042_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07572-3","volume":"22","author":"AR King","year":"2022","unstructured":"King AR, Shah S, Randall LA, Frew PM, Spaulding A, Holloway IW. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban US settings. BMC Infect Dis. 2022;22(1):1\u201312.","journal-title":"BMC Infect Dis"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01042-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-024-01042-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-024-01042-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:37:40Z","timestamp":1719401860000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-024-01042-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1042"],"URL":"https:\/\/doi.org\/10.1186\/s12954-024-01042-6","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Ethics Committee (HREC) of the University of the Witwatersrand (Reference: 200202) and the Emory University Institutional Review Board (IRB) (ID: STUDY00000134).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants (key stakeholders and PWID) were 18 years or older, and provided written informed consent to participate in the survey and\/or IDI, with separate consent for audio recording of their IDIs. Consenting was conducted in <i>IsiZulu<\/i> or English, depending on participant preference.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable, individual data\/images not used.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}